Aaron Cowen’s Veradermics Inc MANE Stock Holding History

Aaron Cowen’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513M	Hold	4,168,970	–	–	9.37%	2
2026 Q1	$263M	Buy	+4,168,970	New	+$210M	6.72%	2

Other funds holding MANE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Aaron Cowen's MANE Position: Q2 2026 in Review

Aaron Cowen held its Veradermics Inc (MANE) position steady in Q2 2026 at 4,168,970 shares worth $513M. The position accounts for 9.37% of the portfolio, ranked #2.

Aaron Cowen first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 163 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

Aaron Cowen held 4,168,970 shares of Veradermics Inc worth $513M as of Q2 2026.
Aaron Cowen left its Veradermics Inc share count unchanged in Q2 2026.
Veradermics Inc made up 9.37% of Aaron Cowen's portfolio in Q2 2026, its #2 holding.
Aaron Cowen first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
163 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.